This scenario was seemingly confirmed by observations that plasma concentrations of three of the ten measured cytokines, IFN-2α, IL-16 and IL-1Ra, were significantly decreased in the group of breast cancer patients, while the concentrations of the remaining seven, including IL-10 and TGF-β1, were comparable with those of the controls. This evidence concerns the gene IL16 and breast cancer.